Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Uranium Energy
UEC
$5.55B
| $5.83M | ﹤0.01% |
1,894,100
+1,367,735
| +260% | +$5.69M |
|
3427
Aegon
AEG
$14B
| $5.83M | ﹤0.01% |
1,362,808
-2,650,038
| -66% | -$13.1M |
|
3428
PUT
Sempra
SRE
$56.5B
| $5.83M | ﹤0.01% |
77,600
-69,200
| -47% | -$5.56M |
|
3429
Community Health Systems
CYH
$423M
| $5.82M | ﹤0.01% |
1,552,848
+982,235
| +172% | +$6.92M |
|
3430
PUT
ProShares UltraShort S&P500
SDS
$366M
| $5.82M | ﹤0.01% |
23,136
+6,032
| +35% | +$1.35M |
|
3431
Stantec
STN
$8.28B
| $5.81M | ﹤0.01% |
132,775
+78,991
| +147% | +$3.62M |
|
3432
Halliburton
HAL
$28.7B
| $5.81M | ﹤0.01% |
185,369
-537,128
| -74% | -$20M |
|
|
FRC
3433
CALL
DELISTED
First Republic Bank
FRC
| $5.81M | ﹤0.01% |
40,300
-55,100
| -58% | -$8.26M |
|
3434
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.47B
| $5.81M | ﹤0.01% |
60,952
+30,913
| +103% | +$3M |
|
3435
CALL
Kulicke & Soffa
KLIC
$5.19B
| $5.8M | ﹤0.01% |
135,400
-21,200
| -14% | -$1.05M |
|
3436
Ralph Lauren
RL
$23.2B
| $5.79M | ﹤0.01% |
64,584
-2,349
| -4% | -$237K |
|
3437
CALL
OneMain Financial
OMF
$7.56B
| $5.79M | ﹤0.01% |
154,800
+36,000
| +30% | +$1.56M |
|
3438
Jackson Financial
JXN
$9.17B
| $5.78M | ﹤0.01% |
216,223
+129,427
| +149% | +$4.72M |
|
3439
CALL
Cal-Maine
CALM
$3.8B
| $5.78M | ﹤0.01% |
117,000
-18,700
| -14% | -$949K |
|
3440
State Street SPDR S&P Retail ETF
XRT
$640M
| $5.78M | ﹤0.01% |
99,337
+65,333
| +192% | +$4.45M |
|
3441
PUT
Allegro MicroSystems
ALGM
$8.27B
| $5.78M | ﹤0.01% |
279,100
-691,000
| -71% | -$16.5M |
|
3442
PUT
iShares Select Dividend ETF
DVY
$24.1B
| $5.77M | ﹤0.01% |
49,000
+20,300
| +71% | +$2.54M |
|
3443
CALL
Nu Holdings
NU
$73.6B
| $5.76M | ﹤0.01% |
1,539,700
+515,600
| +50% | +$2.62M |
|
|
TGH
3444
CALL
DELISTED
Textainer Group Holdings limited
TGH
| $5.76M | ﹤0.01% |
210,000
+54,100
| +35% | +$1.75M |
|
3445
PUT
Boston Properties
BXP
$10.9B
| $5.75M | ﹤0.01% |
64,600
+16,500
| +34% | +$1.83M |
|
3446
BioCryst Pharmaceuticals
BCRX
$2.49B
| $5.74M | ﹤0.01% |
542,461
+93,305
| +21% | +$962K |
|
3447
PUT
Texas Roadhouse
TXRH
$13.6B
| $5.74M | ﹤0.01% |
78,400
+20,100
| +34% | +$1.58M |
|
3448
Jasper Therapeutics
JSPR
$26.3M
| $5.74M | ﹤0.01% |
297,300
-2,158
| -0.7% | -$61.5K |
|
3449
Bloom Energy
BE
$67.7B
| $5.74M | ﹤0.01% |
347,631
-685,125
| -66% | -$12.5M |
|
3450
Sweetgreen
SG
$748M
| $5.74M | ﹤0.01% |
+492,383
| New | +$10.4M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.